GRMN vs ZVRA · P/E 28, rev $7.25B vs P/E 6.3, rev $75.9M
Garmin Ltd (GRMN) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
GRMN currently screens at market cap $41.35B and trailing P/E 28.3. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the GRMN and ZVRA stock pages for the full models.
Not investment advice.